Dr. Jay Simhan, MD

Dr. Simhan practices at Fox Chase Cancer Center in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Simhan's NPI, 1669613113, was assigned on March 12, 2009. Dr. Simhan graduated from University of North Carolina at Chapel Hill School of Medicine in 2007. Dr. Simhan holds Pennsylvania license MD438198.

Dr. Simhan's primary practice is Fox Chase Cancer Center, at 333 Cottman Avenue, Philadelphia, PA 19111.

Dr. Simhan's primary practice is Fox Chase Cancer Center in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Simhan is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Simhan to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Simhan practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Simhan's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Simhan's licenses on file in 2 states: Pennsylvania and Texas.

CMS data shows 735 Medicare services from Dr. Simhan across 14 procedure codes in 2024, for 333 Medicare patients. Medicare paid $102,318 for them.

CMS counts 333 Medicare patients who saw Dr. Simhan in 2024. The largest group is 65 to 74, with 180 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Simhan's median patient age at 71, with 10% women.

In 2024, Dr. Simhan wrote 31 Medicare Part D claims for 20 patients. 74% of them were for generic drugs. They cover 3 drugs, with $262 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

Dr. Simhan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Simhan as offering telehealth.

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 42 papers to Dr. Simhan, published from 2015 to 2025. 2023 was the busiest year, with 10. The most frequent topics are Penile Prosthesis, Penile Implantation and Erectile Dysfunction. Dr. Simhan has published most often in Urology. Dr. Simhan's most frequent co-authors are Martin Simon Gross, MD, David Barham, MD and Faysal Anas Yafi, MD.

CMS Open Payments shows 523 general payments to Dr. Simhan from 22 drug and device companies from 2016 to 2025. Education make up the largest share, 39% of the total. Coloplast Corp paid the most, $214,428. It also lists 3 research payments totaling $27,804 from 2023 to 2024.

Dr. Simhan graduated from University of North Carolina at Chapel Hill School of Medicine in 2007.